The iconic rise of Viagra has long been a symbol of pharmaceutical success, however its legacy within the broader market now triggers questions about future gains. Alternative versions are undercutting exclusivity , causing anxieties that investing in companies heavily reliant to Viagra's once-dominant standing could be a problematic strategy, espe